Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Contract/Agreement, Product/Service, Trade Show

Global Clinical Study Sponsors and Clinical Research Organizations Gather for the "Era of Life Science Transformation" at Medidata NEXT NYC 2019

Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, is set for November 12-13 at Spring Studios in New York City. Medidata NEXT NYC, the centerpiece of Medidata's global conference series, will feature keynote addresses by healthcare industry visionaries, including:

Breakout sessions will highlight best practice advances within each phase of the clinical development lifecycle, including study planning and execution, trial management, data analytics, patient engagement, risk-based monitoring, and launch readiness. Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions.

Medidata NEXT NYC will also host a one-day hackathon, Real Patients, Virtual Trials, to inspire innovation around patient-centric clinical trials. The hackathon will help spur innovators to create novel mobile applications, using the Medidata AppConnect software kit, to increase virtual participation and patient recruitment rates in clinical trials.

"Every aspect of developing new life sciences products is changing thanks to rapid advances in the digital world," said Glen de Vries, co-CEO and co-founder, Medidata. "Medidata NEXT NYC is part of our commitment to bring life science companies together for the common mission of improving people's lives by connecting the dots from research, development, and the real-world practice of medicine."

About Medidata NEXT

Medidata NEXT is the largest annual event series of its kind, and attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries. These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London, New York, Seoul, Shanghai and Tokyo.

About Medidata

Medidata is The Operating System for Life Sciencestm and precision medicine. Medidata helps pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access Medidata's intelligent platform for clinical, commercial, and real-world data insights to create hope for millions of patients. Headquartered in New York City, Medidata has 16 locations around the world and is part of Dassault Systèmes (Euronext Paris: #13065, DSY.PA). Discover more at www.medidata.com, and follow us @Medidata.

These press releases may also interest you

at 20:05
Hemostemix Inc. ("Hemostemix" or the "Company") is pleased to announce that it is proceeding with its non-brokered private placement of units, as announced January 2, 2020 (the "Unit Offering"). In addition, the Company announces it is also...

at 20:05
CSG® has appointed Sudhansu Panigrahi as vice president and center head of the company's India location to lead an expanding group of experts in Bangalore. "CSG is extremely pleased to add such a forward-thinking, qualified member of the...

at 20:05
Cadence Design Systems, Inc. : WHO: Lip-Bu Tan, chief executive officer, Cadence Design Systems, Inc. . WHAT: Mr. Tan will participate in a fireside chat at the Morgan Stanley TMT Conference on March 3, 2020 at the Palace Hotel in San Francisco....

at 20:00
Beverly Hills based Force Protection Agency (FPA), the world's leading Celebrity protective services, executive protection and investigative firm, announced today that it has launched a luxury services division, FPA LUXE. "We are excited to expand...

at 19:55
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common...

at 19:51
Pegasystems Inc. ("Pega") , the software company empowering digital transformation at the world's leading enterprises, today announced the pricing of its offering of $525,000,000 aggregate principal amount of 0.75% Convertible Senior Notes due 2025...

News published on 11 november 2019 at 12:05 and distributed by: